Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.
Systematic Reviews|July 28, 2016
The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic reviewCaroline Main, Madhumita Dandapani, Mark Pritchard, et al.
Journal of the National Cancer Institute|September 20, 2017
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant TherapyStefan Suciu, Alexander M M Eggermont, Paul Lorigan, et al.
Journal of Neurology|December 17, 2010
A randomised controlled trial of treatment for idiopathic intracranial hypertensionAlexandra K Ball, Andrew Howman, Keith Wheatley, et al.
Clinical Linguistics & Phonetics|May 1, 2019
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listenersChristina H Smith, Smitaa Patel, Rebecca L Woolley, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Pilot and Feasibility Studies|January 19, 2018
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot)Catherine M Sackley, Christina H Smith, Caroline E Rick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12Christine J Harrison, Robert K Hills, Anthony V Moorman, et al.
British Journal of Cancer|March 15, 2026
Addition of zoledronic acid to consolidation chemotherapy in Ewing sarcoma-EURO EWING 2012 (EE2012): an international, open-label, randomised controlled phase III trialBrennan Bernadette, Laura Kirton, Perrine Marec-Bérard, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.
Systematic Reviews|July 28, 2016
The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic reviewCaroline Main, Madhumita Dandapani, Mark Pritchard, et al.
Journal of the National Cancer Institute|September 20, 2017
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant TherapyStefan Suciu, Alexander M M Eggermont, Paul Lorigan, et al.
Journal of Neurology|December 17, 2010
A randomised controlled trial of treatment for idiopathic intracranial hypertensionAlexandra K Ball, Andrew Howman, Keith Wheatley, et al.
Clinical Linguistics & Phonetics|May 1, 2019
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listenersChristina H Smith, Smitaa Patel, Rebecca L Woolley, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Pilot and Feasibility Studies|January 19, 2018
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot)Catherine M Sackley, Christina H Smith, Caroline E Rick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12Christine J Harrison, Robert K Hills, Anthony V Moorman, et al.
British Journal of Cancer|March 15, 2026
Addition of zoledronic acid to consolidation chemotherapy in Ewing sarcoma-EURO EWING 2012 (EE2012): an international, open-label, randomised controlled phase III trialBrennan Bernadette, Laura Kirton, Perrine Marec-Bérard, et al.
Pageof 15